Search Orphan Drug Designations and Approvals
-
Generic Name: | Emapalumab |
---|---|
Date Designated: | 09/25/2020 |
Orphan Designation: | Prevention of graft failure following hematopoietic stem cell transplantation |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Sobi AG 12 Chemin des Aulx Plan-Les-Ouates Geneva 1228 Switzerland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-